Background. Central venous catheter-related infections are the most common cause of nosocomial S. aureus bacteraemia in Denmark. Central venous catheters are often used for dialysis, and patients on dialysis often run into staphylococcal infections. The purpose of this study was to investigate S. aureus bacteraemia among dialysis patients, especially those related to dialysis catheters. Methods. This was a retrospective study of 14387 consecutive S. aureus bacteraemia cases during the period 1976-93, of which 793 cases occurred among dialysis patients. By reviewing the case records, 65 dialysis catheter-related cases were described more thoroughly. Results. The number of S. aureus bacteraemia cases among dialysis patients as a proportion of all cases in Denmark has increased from 5.2 to 14.7% during the study period, but the annual incidence among these patients has been almost stable during the period (median 5.7% (3.2-9.0%)). Patients on dialysis had a lower mortality than other patients with S. aureus bacteraemia (18.9 vs 29.0%), but a four times higher mortality from central venous catheter-related S. aureus bacteraemia (5.3 vs 1.3%, P<O.OOI). The mortality from dialysis catheter-related S. aureus bacteraemia was correlated with greater age (median 71 years (57-73) 
Introduction
The number of Staphylococcus aureus bacteraemia cases has increased annually in Denmark during recent decades [1] . This increase is partly due to more intravascular catheter-related infections, which are now the most common cause of nosocomial S. aureus bacteraemia [2] . This information has been provided by a nationwide survey of S. aureus bacteraemia in Denmark, that has been going on since 1957. In this survey, the majority of S. aureus strains isolated from blood cultures have been referred to the Staphylococcus Laboratory at Statens Serum Institut, Copenhagen, Denmark, for phage typing. Clinical information from the individual hospital departments has been provided in approximately 95% of the cases and the data registered in the bacteraemia file.
The purpose of this study was to investigate S. aureus bacteraemia among dialysis patients and to describe more thoroughly those cases related to dialysis catheters by reviewing the case records of 65 dialysis catheter-related cases at Hvidovre Hospital (HH).
Subjects and methods

Patients
During the period 1976-1993 a total of 14387 S. aureus bacteraemia cases were registered in the bacteraemia file. Of these cases, 793 occurred among dialysis patients, and 635 cases were related to central venous catheters. In all, 1074 bacteraemia cases were identified at HH. By reviewing the case records we found that 85 cases were central venous catheter-related and that 65 of these cases were related to dialysis catheters.
Hvidovre Hospital (HH)
HH is a 1000 bed teaching hospital in the South Western part of Copenhagen. In the period 1976-1993 the number of bed-days increased from 16398 to 36266 and the number of discharges increased from 15772 to 18304. The 1074 S. aureus bacteraemia cases registered at HH in the period 1976-1993 occurred in 19 different departments, of which five were located at HH for only a part of the period: Dept. of Haematology (1976 Haematology ( -1990 (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) .
Patient evaluation
For all 14387 S. aureus bacteraemia cases in Denmark the following data were registered: age (registered in lO-year age groups), sex, underlying diseases (diabetes, cirrhosis of the liver, collagenosis, skin diseases, pancreatitis, malignant diseases, and haematological malignancies), the portal of entry (central venous catheters, peripheral catheters, other blood catheters, skin, post-operative wound, lungs or urinary tract). Patients on haemodialysis and peritoneal dialysis were also registered. It was noted if the bacteraemia was complicated with endocarditis or bone or joint infections, and the mortality and the phage-type pattern were also registered.
The following data concerning the 65 dialysis catheterrelated cases at HH were extracted from the patients' case records: age, sex, underlying diseases including uraemia, the anatomical location of the catheter, if blood transfusion or parenteral nutrition was given in the catheter period, if the catheter was changed over a guide-wire and the reason for this, if it occurred, the reason for catheter removal, the number of days after catheter insertion before bacteraemia occurred, signs of infection at the insertion site, results of cultivation from the insertion site and from the catheter tip. The mortality and secondary bacterial complications, if any, were also registered.
Laboratory investigations and phage-type pattern
The catheter tip was cultured semiquantitatively [3] . The phage-types were determined as described in detail elsewhere [4] . The phage-type pattern for dialysis patients and patients with dialysis catheter-related S. aureus bacteraemia was similar to the phage-type pattern for all S. aureus bacteraemia cases in Denmark (DK) (data not shown).
Definitions Central venous catheter-related infection (DKjHH)
An infection is registered as central venous catheter-related in the bacteraemia file containing the 14387 S. aureus bacteraemia cases, if it was concluded on the basis of the clinical information obtained from the individual hospital departments that a central venous catheter was the most likely primary portal of entry. Concerning the 65 dialysis catheter-related cases at HH, the phage-type pattern was taken into account by comparing the phage-type from blood with the phage-type from the catheter tip and from the insertion site. 
Septic shock (HH)
Septic shock was registered if there was an abrupt fall in blood pressure requiring presser supports or rapid infusions and there was no obvious reason for the shock other than the S. aureus bacteraemia.
Endocarditis (DKjHH)
The nationwide bacteraemia file did not register how endocarditis was diagnosed, but all dialysis catheter-related endocarditis cases at HH were verified by echocardiography.
Bone and joint infections (DKjHH)
Neither bone nor joint infections were defined in the nationwide bacteraemia file. At HH one case of osteomyelitis was diagnosed by CT-scanning, but without any microbiological verification. In all cases of arthritis at HH the phage-type isolated from the joint was the same as that in the blood.
Cerebral abscess (HH)
Both cases were diagnosed by CT-scanning without any microbiological verification.
Pneumonia (HH)
In three cases, the phage-type isolated from the sputum was the same as that in the blood. In seven cases microbiological investigation was not performed.
Empyema and urinary tract infections (HH)
In all cases, the phage-type isolated was the same as that in the blood.
Septic vein thrombosis
Septic vein thrombosis was registered if S. aureus bacteraemia occurred and there was obvious signs of thrombophlebitis of the vein in which the central venous catheter was located.
Mortality
Unless anything else is specified, the mortality includes all deaths, also those which were not due to S. aureus bacteraemia.
Statistical analysis
The Xl test and Mann-Whitney U test were applied when appropriate; P < 0.05 was taken as significant. Denmark, 1976 Denmark, -1993 
Results
Staphylococcus au reus bacteraemia in
. Patients on dialysis vs other patients
A total of 14387 S. aureus bacteraemia cases were registered. Of these cases, 793 (5.5%) occurred among dialysis patients. The total number of bacteraemia cases as well as the cases among dialysis patients has increased during the period, from 542 and 28 in 1976 to 1167 and 84 in 1993 respectively ( Figure 1 ). In Denmark there has been a continuous rise in the number of patients undergoing dialysis, from 310 in 1976 to 1200 in 1993 (S . D . Ladefoged, MD, personal communication). So even though the number of S. aureus bacteraemia cases among dialysis patients has increased rapidly since 1985 (Figure 1 ), the annual incidence of S. aureus bacteraemia among these patients has been almost stable since 1976 (Figure 2 , median 5.7%, range 3.2-9.0%). The number of cases among dialysis patients as a proportion of all cases has increased from 5.2% in 1976 to 14.7% in 1993. Dialysis patients with S. aureus bacteraemia were younger than other patients with S. aureus bacteraemia (Table 1 ) and the age distribution showed a peak in the 6th decennium compared with a peak in the 8th decennium for other patients (data not shown). Patients on dialysis had a lower male to female ratio than other patients (Table I ). Dialysis patients with S. aureus bacteraemia had more often diabetes and less often malignant diseases, cirrhosis of the liver, and skin diseases than other patients with S. aureus bacteraemia (Table I) . Most S. aureus bacteraemia cases among dialysis patients were registered as being related to either dialysis (vascular access unspecified) or central venous catheters, while other primary portals of entry were less common than in other patients (Table 1) . Patients on dialysis had a lower mortality than other patients with S. aureus bacteraemia, and they had a lower frequency of S. aureus endocarditis and S. aureus bone and joint infections ( Table 1) .
Patients on dialysis had a four times higher mortality from central venous catheter-related S. aureus bacteraemia than other patients, and they had also a lower mortality from S. aureus bacteraemia originating from the skin or from the lungs ( Table 2 ). The mortality from S. aureus bacteraemia among patients with Hospital, 1976 Hospital, -1993 In all, 65 (6.0%) of S. aureus bacteraemia cases at HH were central venous catheter-related. The same phagetype as in the blood was cultured from the catheter tip in 57 (87.7%) of these cases. In three (4.6%) cases the same phage-type was cultured from the insertion site, in two (3.1%) cases there was obvious signs of local catheter infection, but no culture was obtained, and in the last three (4.6%) cases dialysis catheter-related bacteraemia was just evident from the case records. The median age was 59 years (range and the male: female ratio was 1.95. In 20 cases, blood transfusion was given. None of the patients received parenteral nutrition. Further details of patients and catheters are given in diabetes was higher among patients on dialysis than among other patients, whereas it was lower among patients with cirrhosis of the liver and patients with malignant diseases (Table 2) . 
Hvidovre Hospital compared with the rest ofDenmark
The age distribution among dialysis patients was the same as among dialysis patients in the rest of DK (data not shown). The male: female ratio was approximately 1.50 as in the rest of DK, also among dialysis patients. Compared with the rest of DK, there was a higher frequency of S. aureus bacteraemia with portal of entry in the skin (13. 2s. aureus with the same phage-type as that in the blood was isolated from the insertion site.
Catheter-related S. aureus bacteraemia in HD patients The incidence of S. aureus bacteraemia among dialysis patients in Denmark was almost stable in the period from 1976 to 1993, but the total number has increased, especially since 1985 (Figure 1 ), i.e. S. aureus bacteraemia among patients undergoing dialysis remains an unchanged problem. In the present study, the median incidence of S. aureus bacteraemia among dialysis patients was 5.7% per year (range 3.2-9.0). The true incidence is probably higher since all bacteraemia cases may not be registered because of the retrospective nature of the study. In any case, dialysis patients run a risk of S. aureus bacteraemia that is more than 330 times higher than the risk of S. aureus bacteraemia in the Danish population in general (0.16 per thousand).
In three other studies of patients on haemodialysis [5] [6] [7] the frequency of S. aureus bacteraemia was higher than in our study (14.3, 10.4, 6 .2%), while in one study [8] the frequency was lower (3.0%). The high frequency of S. aureus bacteraemia in dialysis patients seems to be caused, at least to some degree, by the high carrier rate of S. aureus among these patients [9, 10] . Some investigators have had some success in preventing these infections by means of nasal application of mupirocin [9] . In Denmark, mupirocin is not used routinely to eliminate nasal carriage, and this may contribute to the high frequency of S. aureus bacteraemia among dialysis patients in the present study.
In the present study, the frequencies of S. aureus endocarditis and of S. aureus bone and joint infections were both 3.3%. Some other studies also showed low frequencies of endocarditis [5, 6, 11] (1.0, 2.9, 4.0%) and of bone and joint infections [12] (2.1%) in dialysis, while others showed relatively high frequencies of endocarditis [12, 13] (7.4, 6.4%) and bone and joint infections [6, 8, 13 ] (6.8, 11.3, 9.5%). However, the median frequency of S. aureus endocarditis in other studies may suggest that S. aureus endocarditis is less frequent among patients on dialysis than among other patients [5, 6, 8, 12, 13] vs [14] [15] [16] [17] (median 4.7%, range 0-7.4 vs median 16.5%, range 4.3-33.0%) and that S. aureus bone and joint infection is less frequent in patients on dialysis than in other patients [5, 8, 12] vs [14] [15] [16] [17] (median 3.0%, range 2-5.1 vs median 14.4%, range 10.0-33.5%).
In the present study, patients on dialysis had a lower might have ensured early treatment. It could also be that septicaemia was less common in these patients than in other patients with S. aureus bacteraemia. In addition, dialysis catheters may be removed less often in case of bacteraemia than central venous catheters in general, and this could then explain why the mortality from dialysis catheter-related S. aureus bacteraemia was higher than the mortality from S. aureus bacteraemia related to other types of central venous catheters. Immunodeficiencies among patients on dialysis could be another explanation. In dialysis we found a low mortality from S. aureus bacteraemia secondary to skin and lung infections, but we cannot find any explanation for this. Most catheter-related bacteraemia cases occurred during the first 20 days after catheter insertion, which corresponds to another study [7] . The lower frequency of septic vein thrombosis among patients with dialysis catheters than among patients with other types of central venous catheters may be explained by the fact that dialysis catheters were less often used for blood transfusion, or it may reflect that dialysis catheters are routinely locked with heparin after each dialysis procedure. HH did not have a geriatric department or a department for long-term treatment, and this could perhaps explain why the median age of patients with S. aureus bacteraemia was significantly lower at HH than in the rest of Denmark. The catchment area for HH is undoubtedly socially imbalanced in such a way that many chronic alcoholics and drug addicts are treated in the hospital. This may account for the high frequency at HH of S. aureus bacteraemia with primary portal in the skin compared with the rest of Denmark. We do not have any good explanation for the low frequency at HH of S. aureus bone and joint infection [5, 7, 13, 18] vs [14] [15] [16] [17] 19, 20] (median 11.0%, range 4.5-20.0 vs median 25.4%, range 3.4-40.8%). A plausible explanation could be that these patients were already hospitalized when bacteraemia occurred, which and of S. aureus bacteraemia secondary to postoperative wound infections, nor are we able to explain why patients on dialysis have a later onset of central venous catheter-related S. aureus bacteraemia than other patients.
Generally, there is a need for prospective studies in which patients as well as catheters are followed more thoroughly to study the pathogenesis of catheterrelated infections.
